CTT PHARMACEUTICAL HOLDINGS, INC. purchased $116 of CTTH
CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 2,100 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.06 on 2026-08-24.
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 1:09 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$CTTH
Relevance
4/10
Decision brief
The 30-second read
Low
01
Why it matters
The purchase adds marginally to the CEO's holdings and may be viewed as a modest vote of confidence, but the dollar amount is negligible for market impact.
02
Market read
Limited relevance; the trade size is trivial and unlikely to move the stock.
03
What to watch
Potential future insider activity not reflected in this tiny trade
Relevance 4/10Novelty 4/10Timing: after market close 2026-08-24
Background
SEC Form 4 filing reporting a 2,100‑share open‑market purchase by the CEO at $0.055 per share.
Market effects
Sector
minimal impact on pharmaceutical sector
Regional
none
Global
none
Counterpoint
What could challenge this read
Insider purchase is too small to signal confidence
Key entities
- companyCTT Pharmaceutical Holdings, Inc.
Issuer of the Form 4 filing
- personCEO (unnamed)
Insider executing the purchase